New antibody shot could shield against Tick-Borne brain virus
Prevention
Not yet recruiting
This early-stage study tests a lab-made antibody called TBE025 in 18 healthy adults aged 18 to 55. The goal is to see if it is safe and how the body processes it when given through a vein. Participants receive one dose and are closely monitored for side effects. This research hel…
Phase: PHASE1 • Sponsor: Giuseppe Pantaleo • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC